-   comment: In the DrugCentral serine is indicated for
        Pulmonary tuberculosis, however no literature evidences found about the mechanism
        of action of serine treating pulmonary tuberculosis.
    directed: true
    graph:
        disease: Pulmonary tuberculosis
        disease_mesh: MESH:D014397
        drug: serine
        drug_mesh: MESH:D012694
        drugbank: DB:DB00133
    links:
    -   key: treats
        source: MESH:D012694
        target: MESH:D014397
    multigraph: true
    nodes:
    -   id: MESH:D012694
        label: Drug
        name: Serine
    -   id: MESH:D014397
        label: Disease
        name: Pulmonary tuberculosis
    reference: 
    - https://go.drugbank.com/drugs/DB00133
-   comment: In the DrugCentral serine is indicated for
        open-angle glaucoma, however no literature evidences found about the mechanism
        of action of serine treating open-angle glaucoma.
    directed: true
    graph:
        disease: Open-angle glaucoma
        disease_mesh: MESH:D005902
        drug: serine
        drug_mesh: MESH:D012694
        drugbank: DB:DB00133
    links:
    -   key: treats
        source: MESH:D012694
        target: MESH:D005902
    multigraph: true
    nodes:
    -   id: MESH:D012694
        label: Drug
        name: Serine
    -   id: MESH:D005902
        label: Disease
        name: Open-angle glaucoma
    reference:
    - https://go.drugbank.com/drugs/DB00133
-   directed: true
    graph:
        disease: Tyrosinemia type I
        disease_mesh: MESH:D020176
        drug: nitisinone
        drug_mesh: MESH:C077073
        drugbank: DB:DB00348
    links:
    -   key: decreases activity of
        source: MESH:C077073
        target: UniProt:P32754
    -   key: positively regulates
        source: UniProt:P32754
        target: GO:0006572
    -   key: produces
        source: GO:0006572
        target: MESH:C105171
    -   key: contributes to
        source: MESH:C105171
        target: HP:0001394
    -   key: manifestation of 
        source: HP:0001394
        target: MESH:D020176
    multigraph: true
    nodes:
    -   id: MESH:C077073
        label: Drug
        name: Nitisinone
    -   id: UniProt:P32754
        label: Protein
        name: 4-hydroxyphenylpyruvate dioxygenase
    -   id: GO:0006572
        label: BiologicalProcess
        name: Tyrosine catabolic process
    -   id: MESH:C105171
        label: ChemicalSubstance
        name: Fumarylacetoacetate
    -   id: HP:0001394
        label: PhenotypicFeature
        name: Cirrhosis
    -   id: MESH:D020176
        label: Disease
        name: Tyrosinemia type I
    reference: 
    - https://en.wikipedia.org/wiki/Tyrosinemia_type_I
    - https://go.drugbank.com/drugs/DB00348#BE0000455
-   directed: true
    graph:
        disease: Hypercholesterolemia
        disease_mesh: MESH:D006937
        drug: colestipol
        drug_mesh: MESH:D003084
        drugbank: DB:DB00375
    links:
    -   key: decreases abundance of
        source: MESH:D003084
        target: MESH:D001647
    -   key: derives from
        source: MESH:D001647
        target: MESH:D002784
    -   key: positively correlated with
        source: MESH:D002784
        target: MESH:D006937
    -   key: increases activity of
        source: MESH:D003084
        target: UniProt:P01130
    -   key: positively regulates
        source: UniProt:P01130
        target: GO:0034383
    -   key: decreases abundance of
        source: GO:0034383
        target: MESH:D008077
    -   key: positively correlated with
        source: MESH:D008077
        target: MESH:D006937
    multigraph: true
    nodes:
    -   id: MESH:D003084
        label: Drug
        name: Colestipol
    -   id: MESH:D001647
        label: ChemicalSubstance
        name: Bile Acids and Salts
    -   id: MESH:D002784
        label: ChemicalSubstance
        name: Cholesterol
    -   id: UniProt:P01130
        label: Protein
        name: Low-density lipoprotein receptor
    -   id: GO:0034383
        label: BiologicalProcess
        name: Low-density lipoprotein particle clearance
    -   id: MESH:D008077
        label: ChemicalSubstance
        name: Lipoproteins, LDL
    -   id: MESH:D006937
        label: Disease
        name: Hypercholesterolemia
    reference:
    - https://go.drugbank.com/drugs/DB00375#BE0004809
-   directed: true
    graph:
        disease: Hyperlipidemia
        disease_mesh: MESH:D006949
        drug: colestipol
        drug_mesh: MESH:D003084
        drugbank: DB:DB00375
    links:
    -   key: decreases abundance of
        source: MESH:D003084
        target: MESH:D001647
    -   key: derives from
        source: MESH:D001647
        target: MESH:D002784
    -   key: positively correlated with
        source: MESH:D002784
        target: MESH:D006949
    -   key: increases activity of
        source: MESH:D003084
        target: UniProt:P01130
    -   key: positively regulates
        source: UniProt:P01130
        target: GO:0034383
    -   key: decreases abundance of
        source: GO:0034383
        target: MESH:D008077
    -   key: positively correlated with
        source: MESH:D008077
        target: MESH:D006949
    multigraph: true
    nodes:
    -   id: MESH:D003084
        label: Drug
        name: Colestipol
    -   id: MESH:D001647
        label: ChemicalSubstance
        name: Bile Acids and Salts
    -   id: MESH:D002784
        label: ChemicalSubstance
        name: Cholesterol
    -   id: UniProt:P01130
        label: Protein
        name: Low-density lipoprotein receptor
    -   id: GO:0034383
        label: BiologicalProcess
        name: Low-density lipoprotein particle clearance
    -   id: MESH:D008077
        label: ChemicalSubstance
        name: Lipoproteins, LDL
    -   id: MESH:D006949
        label: Disease
        name: Hyperlipidemia
    reference:
    - https://go.drugbank.com/drugs/DB00375#BE0004809
-   directed: true
    graph:
        disease: Hypertensive disorder
        disease_mesh: MESH:D006973
        drug: guanabenz
        drug_mesh: MESH:D006143
        drugbank: DB:DB00629
    links:
    -   key: increases activity of
        source: MESH:D006143
        target: UniProt:P08913
    -   key: positively correlated with
        source: UniProt:P08913
        target: GO:0004938
    -   key: negatively regulates
        source: GO:0004938
        target: GO:0061533
    -   key: positively regulates
        source: GO:0061533
        target: HP:0000822
    -   key: positively correlated with
        source: HP:0000822
        target: MESH:D006973
    multigraph: true
    nodes:
    -   id: MESH:D006143
        label: Drug
        name: Guanabenz
    -   id: UniProt:P08913
        label: Protein
        name: Alpha-2A adrenergic receptor
    -   id: GO:0004938
        label: BiologicalProcess
        name: Alpha2-adrenergic receptor activity
    -   id: GO:0061533
        label: BiologicalProcess
        name: Norepinephrine secretion, neurotransmission
    -   id: HP:0000822
        label: PhenotypicFeature
        name: Blood pressure
    -   id: MESH:D006973
        label: Disease
        name: Hypertensive disorder
    reference:
    - https://go.drugbank.com/drugs/DB00629
-   comment: Tamoxifen is a selective estrogen receptor modulator used to treat estrogen receptor positive breast cancer.
    directed: true
    graph:
        disease: Infiltrating duct carcinoma of breast
        disease_mesh: MESH:D018270
        drug: tamoxifen
        drug_mesh: MESH:D013629
        drugbank: DB:DB00675
    links:
    -   key: decreases activity of
        source: MESH:D013629
        target: UniProt:P03372
    -   key: participates in
        source: UniProt:P03372
        target: GO:0030284
    -   key: positively regulates
        source: GO:0030284
        target: GO:0008283
    -   key: decreases activity of
        source: MESH:D013629
        target: UniProt:Q92731
    -   key: participates in
        source: UniProt:Q92731
        target: GO:0030284
    -   key: positively correlated with
        source: GO:0008283
        target: MESH:D018270
    multigraph: true
    nodes:
    -   id: MESH:D013629
        label: Drug
        name: Tamoxifen
    -   id: UniProt:P03372
        label: Protein
        name: Estrogen receptor
    -   id: GO:0030284
        label: MolecularActivity
        name: Estrogen receptor activity
    -   id: GO:0008283
        label: BiologicalProcess
        name: Cell population proliferation
    -   id: UniProt:Q92731
        label: Protein
        name: Estrogen receptor beta
    -   id: MESH:D018270
        label: Disease
        name: Infiltrating duct carcinoma of breast
    reference: 
    - https://go.drugbank.com/drugs/DB00675#BE0000123
-   comment: Contraindicated
    directed: true
    graph:
        disease: Acne vulgaris
        disease_mesh: MESH:D000152
        drug: norethisterone
        drug_mesh: MESH:D009640
        drugbank: DB:DB00717
    links:
    -   key: increases activity of
        source: MESH:D009640
        target: UniProt:P10275
    -   key: molecularly interacts with
        source: UniProt:P10275
        target: MESH:D000728
    -   key: contributes to 
        source: MESH:D000728
        target: MESH:D000152
    multigraph: true
    nodes:
    -   id: MESH:D009640
        label: Drug
        name: Norethisterone
    -   id: UniProt:P10275
        label: Protein
        name: Androgen receptor
    -   id: MESH:D000728
        label: ChemicalSubstance
        name: Androgens
    -   id: MESH:D000152
        label: Disease
        name: Acne vulgaris
    reference: 
    - https://go.drugbank.com/drugs/DB00717
    - https://en.wikipedia.org/wiki/Norethisterone#Side_effects
-   directed: true
    graph:
        disease: Endometriosis
        disease_mesh: MESH:D004715
        drug: norethindrone acetate
        drug_mesh: MESH:C024262
        drugbank: DB:DB00717
    links:
    -   key: increases activity of
        source: MESH:C024262
        target: UniProt:P06401
    -   key: molecularly interacts with
        source: UniProt:P06401
        target: MESH:D011374
    -   key: negatively regulates
        source: MESH:D011374
        target: GO:0008283
    -   key: located in
        source: GO:0008283
        target: UBERON:0001295
    -   key: positively correlated with
        source: UBERON:0001295
        target: MESH:D004715
    multigraph: true
    nodes:
    -   id: MESH:C024262
        label: Drug
        name: Norethindrone acetate
    -   id: UniProt:P06401
        label: Protein
        name: Progesterone receptor
    -   id: MESH:D011374
        label: ChemicalSubstance
        name: Progesterone
    -   id: GO:0008283
        label: BiologicalProcess
        name: Cell population proliferation
    -   id: UBERON:0001295
        label: GrossAnatomicalStructure
        name: Endometrium
    -   id: MESH:D004715
        label: Disease
        name: Endometriosis
    reference:
    - https://go.drugbank.com/drugs/DB00717
-   comment: Only combination of estradiol and norethindrone is used for the treatment of atrophic vaginitis.
        Please refer to this curation DB00783_MESH_D059268_1 for MoA.
    directed: true
    graph:
        disease: Atrophic vaginitis
        disease_mesh: MESH:D059268
        drug: norethindrone acetate
        drug_mesh: MESH:D009640
        drugbank: DB:DB00717
    links:
    -   key: treats
        source: MESH:D009640
        target: MESH:D059268 
    multigraph: true
    nodes:
    -   id: MESH:D009640
        label: Drug
        name: Norethisterone
    -   id: MESH:D059268
        label: Disease
        name: Atrophic vaginitis
    reference:
    - https://go.drugbank.com/drugs/DB00717
-   directed: true
    graph:
        disease: Menorrhagia
        disease_mesh: MESH:D008595
        drug: norethisterone
        drug_mesh: MESH:D009640
        drugbank: DB:DB00717
    links:
    -   key: increases activity of
        source: MESH:D009640
        target: UniProt:P06401
    -   key: negatively regulates
        source: UniProt:P06401
        target: GO:0050673
    -   key: located in
        source: GO:0050673
        target: UBERON:0001295
    -   key: correlated with
        source: UBERON:0001295
        target: HP:0030126
    -   key: causes
        source: HP:0030126
        target: MESH:D008595
    multigraph: true
    nodes:
    -   id: MESH:D009640
        label: Drug
        name: Norethisterone
    -   id: UniProt:P06401
        label: Protein
        name: Progesterone receptor
    -   id: UBERON:0001295
        label: GrossAnatomicalStructure
        name: Endometrium
    -   id: HP:0030126
        label: PhenotypicFeature
        name: Abnormality of the endometrium
    -   id: GO:0050673
        label: BiologicalProcess
        name: Epithelial cell proliferation
    -   id: MESH:D008595
        label: Disease
        name: Menorrhagia
    reference:
    - https://go.drugbank.com/drugs/DB00717#BE0000557
    - https://pubmed.ncbi.nlm.nih.gov/8671392/
-   directed: true
    graph:
        disease: Dysfunctional uterine bleeding
        disease_mesh: MESH:D008796
        drug: norethisterone
        drug_mesh: MESH:D009640
        drugbank: DB:DB00717
    links:
    -   key: increases activity of
        source: MESH:D009640
        target: UniProt:P06401
    -   key: negatively regulates
        source: UniProt:P06401
        target: GO:0050673
    -   key: located in
        source: GO:0050673
        target: UBERON:0001295
    -   key: correlated with
        source: UBERON:0001295
        target: HP:0030126
    -   key: causes
        source: HP:0030126
        target: MESH:D008796
    multigraph: true
    nodes:
    -   id: MESH:D009640
        label: Drug
        name: Norethisterone
    -   id: UniProt:P06401
        label: Protein
        name: Progesterone receptor
    -   id: UBERON:0001295
        label: GrossAnatomicalStructure
        name: Endometrium
    -   id: HP:0030126
        label: PhenotypicFeature
        name: Abnormality of the endometrium
    -   id: GO:0050673
        label: BiologicalProcess
        name: Epithelial cell proliferation
    -   id: MESH:D008796
        label: Disease
        name: Dysfunctional uterine bleeding
    reference:
    - https://go.drugbank.com/drugs/DB00717#BE0000557
    - https://pubmed.ncbi.nlm.nih.gov/8671392/
-   comment: Only combination of Estradiol and norethindrone is used for the treatment of menopausal flushing.
      Please refer to this curation DB00783_MESH_D019584_1 for MoA.
    directed: true
    graph:
        disease: Menopausal flushing
        disease_mesh: MESH:D019584
        drug: norethisterone
        drug_mesh: MESH:D009640
        drugbank: DB:DB00717
    links:
    -   key: treats
        source: MESH:D009640
        target: MESH:D019584
    multigraph: true
    nodes:
    -   id: MESH:D009640
        label: Drug
        name: Norethisterone
    -   id: MESH:D019584
        label: Disease
        name: Menopausal flushing
    reference:
    - https://go.drugbank.com/drugs/DB00717#BE0000557
-   comment: Only combination of estradiol and norethindrone is used for the treatment of postmenopausal osteoporosis.
      Please refer to this curation DB00783_MESH_D015663_1 for MoA.
    directed: true
    graph:
        disease: Postmenopausal osteoporosis
        disease_mesh: MESH:D015663
        drug: norethisterone
        drug_mesh: MESH:D009640
        drugbank: DB:DB00717
    links:
    -   key: treats
        source: MESH:D009640
        target: MESH:D015663
    multigraph: true
    nodes:
    -   id: MESH:D009640
        label: Drug
        name: Norethisterone
    -   id: MESH:D015663
        label: Disease
        name: Postmenopausal osteoporosis
    reference:
    - https://go.drugbank.com/drugs/DB00717#BE0000557
-   comment: It is not approved for use in the United States, but is approved in other Western countries such as Canada, the UK and Australia.
    directed: true
    graph:
        disease: Depressive disorder
        disease_mesh: MESH:D003866
        drug: moclobemide
        drug_mesh: MESH:D020912
        drugbank: DB:DB01171
    links:
    -   key: negatively regulates
        source: MESH:D020912
        target: UniProt:P21397
    -   key: positively regulates
        source: UniProt:P21397
        target: GO:0042402
    -   key: decreases abundance of
        source: GO:0042402
        target: MESH:D012701
    -   key: decreases abundance of
        source: GO:0042402
        target: MESH:D009638
    -   key: positively correlated with
        source: MESH:D012701
        target: GO:0099153
    -   key: positively correlated with
        source: MESH:D009638
        target: GO:0099155
    -   key: disrupted by
        source: GO:0099153
        target: MESH:D003866
    -   key: disrupted by
        source: GO:0099155
        target: MESH:D003866
    multigraph: true
    nodes:
    -   id: MESH:D020912
        label: Drug
        name: Moclobemide
    -   id: UniProt:P21397
        label: Protein
        name: Amine oxidase [flavin-containing] A
    -   id: GO:0042402
        label: BiologicalProcess
        name: Cellular biogenic amine catabolic process
    -   id: MESH:D009638
        label: ChemicalSubstance
        name: Norepinephrine
    -   id: MESH:D012701
        label: ChemicalSubstance
        name: Serotonin
    -   id: GO:0099153
        label: BiologicalProcess
        name: Synaptic transmission, serotonergic
    -   id: GO:0099155
        label: BiologicalProcess
        name: Synaptic transmission, noradrenergic
    -   id: MESH:D003866
        label: Disease
        name: Depressive disorder
    reference:
    - https://pubmed.ncbi.nlm.nih.gov/26104056/
    - https://www.ncbi.nlm.nih.gov/books/NBK539848/
    - https://pubmed.ncbi.nlm.nih.gov/12369606/
    - https://go.drugbank.com/drugs/DB01171
-   directed: true
    graph:
        disease: Mucopolysaccharidosis, MPS-II
        disease_mesh: MESH:D016532
        drug: idursulfase
        drug_mesh: MESH:C517982,MESH:D007066
        drugbank: DB:DB01271
    links:
    -   key: chemically similar to
        source: DB:DB01271
        target: UniProt:P22304
    -   key: decreases abundance of
        source: UniProt:P22304
        target: MESH:D006497
    -   key: decreases abundance of
        source: UniProt:P22304
        target: MESH:D003871
    -   key: contributes to
        source: MESH:D006497
        target: MESH:D016532
    -   key: contributes to
        source: MESH:D003871
        target: MESH:D016532
    multigraph: true
    nodes:
    -   id: DB:DB01271
        label: Drug
        name: Idursulfase
    -   id: UniProt:P22304
        label: Protein
        name: Iduronate 2-sulfatase
    -   id: MESH:D006497
        label: ChemicalSubstance
        name: Heparitin Sulfate
    -   id: MESH:D003871
        label: ChemicalSubstance
        name: Dermatan Sulfate
    -   id: MESH:D016532
        label: Disease
        name: Mucopolysaccharidosis, MPS-II
    reference: 
    - https://go.drugbank.com/drugs/DB01271
-   comment: In fibrocystic breast disease, the exact mechanism of action of danazol is unknown, but may be related to
        suppressed estrogenic stimulation as a result of decreased ovarian production of estrogen.
    directed: true
    graph:
        disease: Fibrocystic breast changes
        disease_mesh: MESH:D005348
        drug: danazol
        drug_mesh: MESH:D003613
        drugbank: DB:DB01406
    links:
    -   key: decreases activity of
        source: MESH:D003613
        target: UniProt:P30968
    -   key: increases abundance of
        source: UniProt:P30968
        target: MESH:D006065
    -   key: positively regulates
        source: MESH:D006065
        target: GO:0006703
    -   key: increases abundance of
        source: GO:0006703
        target: MESH:D004967
    -   key: positively correlated with
        source: MESH:D004967
        target: MESH:D005348
    multigraph: true
    nodes:
    -   id: MESH:D003613
        label: Drug
        name: Danazol
    -   id: UniProt:P30968
        label: Protein
        name: Gonadotropin-releasing hormone receptor
    -   id: MESH:D006065
        label: ChemicalSubstance
        name: Gonadotropins, Pituitary
    -   id: GO:0006703
        label: BiologicalProcess
        name: Estrogen biosynthetic process
    -   id: MESH:D004967
        label: ChemicalSubstance
        name: Estrogens
    -   id: MESH:D005348
        label: Disease
        name: Fibrocystic breast changes
    reference: 
    - https://go.drugbank.com/drugs/DB01406
-   directed: true
    graph:
        disease: Endometriosis
        disease_mesh: MESH:D004715
        drug: danazol
        drug_mesh: MESH:D003613
        drugbank: DB:DB01406
    links:
    -   key: decreases activity of
        source: MESH:D003613
        target: UniProt:P30968
    -   key: increases abundance of
        source: UniProt:P30968
        target: MESH:D006065
    -   key: positively regulates
        source: MESH:D006065
        target: GO:0006703
    -   key: increases abundance of
        source: GO:0006703
        target: MESH:D004967
    -   key: positively correlated with
        source: MESH:D004967
        target: MESH:D004715
    -   key: increases activity of
        source: MESH:D003613
        target: UniProt:P10275
    -   key: participates in
        source: UniProt:P10275
        target: GO:0030521
    -   key: treats
        source: GO:0030521
        target: MESH:D004715
    multigraph: true
    nodes:
    -   id: MESH:D003613
        label: Drug
        name: Danazol
    -   id: UniProt:P30968
        label: Protein
        name: Gonadotropin-releasing hormone receptor
    -   id: MESH:D006065
        label: ChemicalSubstance
        name: Gonadotropins, Pituitary
    -   id: GO:0006703
        label: BiologicalProcess
        name: Estrogen biosynthetic process
    -   id: MESH:D004967
        label: ChemicalSubstance
        name: Estrogens
    -   id: UniProt:P10275
        label: Protein
        name: Androgen receptor
    -   id: GO:0030521
        label: BiologicalProcess
        name: Androgen receptor signaling pathway
    -   id: MESH:D004715
        label: Disease
        name: Endometriosis
    reference: 
    - https://go.drugbank.com/drugs/DB01406
-   directed: true
    graph:
        disease: Hereditary factor IX deficiency disease
        disease_mesh: MESH:D002836
        drug: eftrenonacog alfa
        drug_mesh: MESH:C000599709
        drugbank: DB:DB11608
    links:
    -   key: chemically similar to
        source: MESH:C000599709
        target: UniProt:P00740
    -   key: participates in
        source: UniProt:P00740
        target: GO:0007597
    -   key: positively regulates
        source: GO:0007597
        target: GO:0072378
    -   key: negatively correlated with
        source: GO:0072378
        target: MESH:D002836
    multigraph: true
    nodes:
    -   id: MESH:C000599709
        label: Disease
        name: Eftrenonacog alfa
    -   id: UniProt:P00740
        label: Protein
        name: Coagulation factor IX
    -   id: GO:0007597
        label: BiologicalProcess
        name: Blood coagulation, intrinsic pathway
    -   id: GO:0072378
        label: BiologicalProcess
        name: Blood coagulation, fibrin clot formation
    -   id: MESH:D002836
        label: Disease
        name: Hereditary factor IX deficiency disease
    reference:
    - https://go.drugbank.com/drugs/DB11608
-   directed: true
    graph:
        disease: Clostridium difficile infection
        disease_mesh: MESH:D003015
        drug: bezlotoxumab
        drug_mesh: MESH:C000613978
        drugbank: DB:DB13140
    links:
    -   key: decreases activity of
        source: MESH:C000613978
        target: UniProt:P18177
    -   key: produced by
        source: UniProt:P18177
        target: NCBITaxon:1496
    -   key: causes
        source: NCBITaxon:1496
        target: MESH:D003015
    multigraph: true
    nodes:
    -   id: MESH:C000613978
        label: Drug
        name: Bezlotoxumab
    -   id: UniProt:P18177
        label: Protein
        name: Toxin B
    -   id: NCBITaxon:1496
        label: OrganismTaxon
        name: Clostridioides difficile 
    -   id: MESH:D003015
        label: Disease
        name: Clostridium difficile infection
    reference: 
    - https://go.drugbank.com/drugs/DB13140#BE0008671
